Disclosures for " Impact of Diabetes Mellitus on Clinical Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy "
-
Dr. Sharma has nothing to disclose.
-
Mr. Jaffry has nothing to disclose.
-
Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
-
The institution of Dr. Hillen has received research support from Genentech.